RxDoctor Payments Data

Raymond Kim, MD

Cardiovascular Disease · Durham, NCNPI 1396829206

Payments from drug & device makers

What this record shows

This record is dominated by consulting fees: $44,325 of the $54,762 with a category attached, or 80.9%. Boehringer Ingelheim International GmbH accounts for 61.2% of it on its own, with 3 other manufacturers making up the rest. Among cardiovascular disease clinicians in NC with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$54,762in general payments, 2019–2025

Across 31 payments — averaging $1766.51 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Boehringer Ingelheim International GmbH$34K
  • Boehringer Ingelheim$10K
  • Siemens Medical Solutions USA, Inc.$9K
  • Pfizer$2K
$242,588in research payments, 2019–2025

Across 15 payments — averaging $16,173 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.

  • Merck$175K
  • Bayer$67K
  • Siemens Medical Solutions USA, Inc.$668

What the payments were for

  • Consulting fees$44,32581%
  • Travel & lodging$9,94818%
  • Food & beverage$4881%

General payments by program year

19
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$54,762 in reported general payments places this provider in the 90th percentile of 727 cardiovascular disease providers in North Carolina.

See all cardiovascular disease providers in North Carolina

Medicare billing

Part B allowed, 2024
$23,809
Medicare patients
146
Services billed
394

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Other cardiovascular disease in Durham

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →